Companies House 15890409 2025-08-31 2025-08-31 2024-08-12 false iso4217:GBP xbrli:pure 15890409 2025-08-31 15890409 2024-08-12 2025-08-31 15890409 curr:PoundSterling 2024-08-12 2025-08-31 15890409 uk-bus:CompanyLimitedByGuarantee 2024-08-12 2025-08-31 15890409 uk-bus:FRS102 2024-08-12 2025-08-31 15890409 uk-bus:AuditExempt-NoAccountantsReport 2024-08-12 2025-08-31 15890409 uk-bus:FullAccounts 2024-08-12 2025-08-31 15890409 uk-bus:RegisteredOffice 2024-08-12 2025-08-31 15890409 uk-bus:Director1 2024-08-12 2025-08-31 15890409 uk-bus:Director2 2024-08-12 2025-08-31 15890409 uk-bus:Director3 2024-08-12 2025-08-31 15890409 uk-bus:Director4 2024-08-12 2025-08-31 15890409 uk-bus:Director5 2024-08-12 2025-08-31 15890409 uk-bus:Director6 2024-08-12 2025-08-31 15890409 uk-bus:Director7 2024-08-12 2025-08-31 15890409 uk-bus:Director8 2024-08-12 2025-08-31 15890409 uk-bus:Director9 2024-08-12 2025-08-31 15890409 uk-bus:Director10 2024-08-12 2025-08-31 15890409 uk-bus:Director11 2024-08-12 2025-08-31 15890409 uk-bus:Director12 2024-08-12 2025-08-31 15890409 uk-bus:Director13 2024-08-12 2025-08-31 15890409 uk-bus:Director14 2024-08-12 2025-08-31 15890409 uk-bus:Director15 2024-08-12 2025-08-31 15890409 uk-bus:Director16 2024-08-12 2025-08-31 15890409 uk-bus:Director17 2024-08-12 2025-08-31 15890409 uk-bus:Director18 2024-08-12 2025-08-31 15890409 uk-bus:Director19 2024-08-12 2025-08-31 15890409 uk-bus:Director20 2024-08-12 2025-08-31 15890409 uk-bus:Director21 2024-08-12 2025-08-31 15890409 uk-bus:CompanySecretary1 2024-08-12 2025-08-31 15890409 core:AfterOneYear 2025-08-31 15890409 core:WithinOneYear 2025-08-31 15890409 core:WithinOneYear 2024-08-12 2025-08-31 15890409 core:AfterOneYear 2025-08-31 15890409 core:AfterOneYear 2024-08-12 2025-08-31 15890409 core:ShareCapital 2025-08-31 15890409 core:SharePremium 2025-08-31 15890409 core:OtherReservesSubtotal 2025-08-31 15890409 core:RevaluationReserve 2025-08-31 15890409 core:RetainedEarningsAccumulatedLosses 2025-08-31 15890409 1 2024-08-12 2025-08-31 15890409 2 2024-08-12 2025-08-31 15890409 3 2024-08-12 2025-08-31 15890409 core:LandBuildings 2024-08-12 2025-08-31 15890409 core:LandBuildings 2025-08-31 15890409 core:PlantMachinery 2024-08-12 2025-08-31 15890409 core:PlantMachinery 2025-08-31 15890409 core:FurnitureFittingsToolsEquipment 2024-08-12 2025-08-31 15890409 core:FurnitureFittingsToolsEquipment 2025-08-31 15890409 core:OfficeEquipment 2024-08-12 2025-08-31 15890409 core:OfficeEquipment 2025-08-31 15890409 core:Vehicles 2024-08-12 2025-08-31 15890409 core:Vehicles 2025-08-31 15890409 core:NetGoodwill 2024-08-12 2025-08-31 15890409 core:NetGoodwill 2025-08-31 15890409 core:IntangibleAssetsOtherThanGoodwill 2024-08-12 2025-08-31 15890409 core:IntangibleAssetsOtherThanGoodwill 2025-08-31

# INNOVATE CLINICAL CARE GROUP CIC

## Company limited by guarantee

## Company Registration Number:
15890409 (England and Wales)

## Unaudited statutory accounts for the year ended 31 August 2025

## Period of accounts

## Start date: 12 August 2024

## End date: 31 August 2025

# INNOVATE CLINICAL CARE GROUP CIC

## Contents of the Financial Statements

for the Period Ended 31 August 2025

Balance sheet |
Additional notes |
Community Interest Report |

# INNOVATE CLINICAL CARE GROUP CIC

## Balance sheet

As at 31 August 2025

| Notes | 13 months to 31 August 2025
--- | --- | ---
|  | £
Current assets
Cash at bank and in hand: |  | 1 |
Total current assets: |  | 1
Net current assets (liabilities): |  | 1
Total assets less current liabilities: |  | 1
Total net assets (liabilities): |  | 1
Members' funds
Profit and loss account: |  | 1 |
Total members' funds: |  | 1

The notes form part of these financial statements

# INNOVATE CLINICAL CARE GROUP CIC

## Balance sheet statements

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 20 May 2026
and signed on behalf of the board by:

Name: Jane Harris
Status: Director

The notes form part of these financial statements

# INNOVATE CLINICAL CARE GROUP CIC

## Notes to the Financial Statements

for the Period Ended 31 August 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

# INNOVATE CLINICAL CARE GROUP CIC

## Notes to the Financial Statements

for the Period Ended 31 August 2025

- ## 2. Employees

  | 13 months to 31 August 2025
  --- | ---
  Average number of employees during the period | 0 |

# COMMUNITY INTEREST ANNUAL REPORT

### INNOVATE CLINICAL CARE GROUP CIC

### Company Number: 15890409 (England and Wales)

### Year Ending: 31 August 2025

Company activities and impact

The company has been dormant this financial year but has since started providing Clinical Care for young people with special needs and learning disabilites

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
20 May 2026

And signed on behalf of the board by:
Name: Jane Harris
Status: Director